Sean Van Helden, PharmD

home / authors / sean-van-helden-pharmd

Van Helden is a Postdoctoral Infectious Diseases Pharmacotherapy fellow at Wayne State University.

Articles

Reviewing the Efficacy and Safety of Omadacycline in Immunocompromised Patients

Reviewing the Efficacy and Safety of Omadacycline in Immunocompromised Patients

John Parkinson;Sean Van Helden, PharmD
June 3rd 2025

In a new study presented at MAD-ID, omadacycline was found to have an 86% clinical success rate across a wide-range of infections and pathogens in an immunocompromised population.

Read More

Expanding the Antibiotic Stewardship Team Can Lead to Greater Adoption of Practices

Expanding the Antibiotic Stewardship Team Can Lead to Greater Adoption of Practices

Sean Van Helden, PharmD;David R. Ha, PharmD, BCIDP
March 27th 2024

There is value in leveraging the contributions of nurses, laboratorians, and informaticists in antimicrobial stewardship.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Merck’s Clesrovimab (Enflonsia) Receives FDA Approval to Protect Infants From RSV During First Season
Published: June 11th 2025 | Updated: June 11th 2025
Merck’s Clesrovimab (Enflonsia) Receives FDA Approval to Protect Infants From RSV During First Season
HHS Secretary RFK Jr Replaces CDC Vaccine Advisory Panel With New Appointees
Published: June 12th 2025 | Updated: June 14th 2025
HHS Secretary RFK Jr Replaces CDC Vaccine Advisory Panel With New Appointees
No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections
Published: June 4th 2025 | Updated: June 14th 2025
No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections
'Tis the Season: Addressing Tick-Borne Illnesses
Published: June 6th 2025 | Updated: June 14th 2025
'Tis the Season: Addressing Tick-Borne Illnesses
Phytocannabinoids Demonstrate Fungicidal Activity and Inhibit Fungal Virulence Factors
Published: June 9th 2025 | Updated: June 14th 2025
Phytocannabinoids Demonstrate Fungicidal Activity and Inhibit Fungal Virulence Factors
© 2025 MJH Life Sciences

All rights reserved.